Skip to main content

Table 1 Demographic characteristics in the training set

From: Construction and validation of a risk prediction model for delayed discharge in elderly patients with hip fracture

Characteristics

Delayed discharge (n = 137)

Non-delayed discharge (n = 734)

t/z/χ2

P value

Age n (%)

  

5.657

0.059

 65–80

134(56.5)

418(64.9)

  

 81–90

89(37.6)

201(31.2)

  

 > 90

14(5.9)

25(3.9)

  

Preoperative waiting time n (%)

  

117.207

 < 0.001

 ≤ 48 h

18(7.6)

304(47.2)

  

 > 48 h

219(92.4)

430(52.8)

  

Gender n (%)

  

0.895

0.344

 Female

168 (70.9)

435 (67.5)

  

 Male

69 (29.1)

209 (32.5)

  

Type of operation n (%)

  

0.207

0.649

 Hip arthroplasty

131(55.3)

367(57.0)

  

 internal fixation

106(44.7)

277(43.0)

  

 Injury types n (%)

  

1.561

0.212

 Low-energy injury

225 (94.9)

623 (96.7)

  

 High-energy injury

12 (5.1)

21 (3.3)

  

 Fracture types n (%)

  

4.484

0.106

 Femoral neck fracture

134 (56.5)

395 (61.3)

  

 Intertrochanteric fracture

99 (41.8)

246 (38.2)

  

 Subtrochanteric fracture

4 (1.7)

3 (0.5)

  

CCI n (%)

  

82.579

 < 0.001

 ≤ 3

170(71.7)

606(94.1)

  

 > 4

67(28.3)

38(5.9)

  

Multiple trauma n (%)

  

7.596

 < 0.001

 No

197(83.1)

579(89.9)

  

 Yes

40(16.9)

65(10.1)

  

Hypertension n (%)

  

1.920

0.166

 No

102(43.0)

311(48.3)

  

 Yes

135(57.0)

333(57.1)

  

Coronary artery disease n (%)

  

36.829

 < 0.001

 No

141(59.5)

513(79.7)

  

 Yes

96(40.5)

131(20.3)

  

Diabetes n (%)

  

2.419

0.120

 No

158(66.7)

464(72.0)

  

 Yes

79(33.3)

180(28.0)

  

Cerebral vascular disease n (%)

  

14.561

 < 0.001

 No

200(84.4)

598(92.9)

  

 Yes

37(15.6)

46(7.1)

  

Hemiplegia n (%)

  

13.086

 < 0.001

 No

192(81.0)

580(90.1)

  

 Yes

45(19.0)

64(9.9)

  

Miocardial infarction n (%)

  

3.035

0.081

 No

233(98.3)

642(99.7)

  

 Yes

4(1.7)

2(0.3)

  

Heart failure n (%)

  

11.079

0.001

 No

223(94.1)

633(98.3)

  

 Yes

14(5.9)

11(1.7)

  

Arrhythmia n (%)

  

6.847

0.009

 No

203(85.7)

590(91.6)

  

 Yes

34(14.3)

54(8.4)

  

Chronic lung disease n (%)

  

26.625

 < 0.001

 No

206(86.9)

619(96.1)

  

 Yes

31(13.1)

25(3.9)

  

Connective tissue disease n (%)

  

2.095

0.148

 No

230(97.0)

636(98.8)

  

 Yes

7(3.0)

8(1.2)

  

Renal insufficiency n (%)

  

2.283

0.131

 No

229(96.6)

633(98.3)

  

 Yes

8(3.4)

11(1.7)

  

Liver insufficiency n (%)

  

2.217

0.136

 No

231(97.5)

638(99.1)

  

 Yes

6(2.5)

6(0.9)

  

Anemia n (%)

  

114.275

 < 0.001

 No

150(63.3)

596(92.5)

  

 Yes

87(36.7)

48(7.5)

  

Hypoproteinemia n (%)

  

115.305

 < 0.001

 No

127(53.6)

562(87.3)

  

 Yes

110(46.4)

82(12.7)

  

Electrolyte disorder n (%)

  

93.081

 < 0.001

 No

165(69.6)

605(93.9)

  

 Yes

72(30.4)

39(6.1)

  

Malignant tumor n (%)

  

6.520

0.011

 No

12 (6.5)

14 (19.5)

  

 Yes

108 (113.5)

345 (339.5)

  

Dementia n (%)

  

2.283

0.131

 No

229(96.6)

633(98.3)

  

 Yes

8(3.4)

11(1.7)

  

Parkinson's disease n (%)

  

0.078

0.781

 No

234(98.7)

639(99.2)

  

 Yes

3(1.3)

5(0.8)

  

Arteriosclerosis of lower limbs n (%)

  

66.146

 < 0.001

 No

170(71.7)

596(92.5)

  

 Yes

67(28.3)

48(7.5)

  

Secondary fracture n (%)

  

7.190

0.007

 No

231(97.5)

642(99.7)

  

 Yes

6(2.5)

2(0.3)

  

Delirium n (%)

  

12.917

 < 0.001

 No

222(93.7)

633(98.3)

  

 Yes

15(6.3)

11(1.7)

 Â